Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |